NasdaqCM - Nasdaq Real Time Price USD
Tempest Therapeutics, Inc. (TPST)
6.49
-0.36
(-5.26%)
At close: May 9 at 4:00:00 PM EDT
7.00
+0.51
+(7.86%)
After hours: May 9 at 7:38:17 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -3.29 | -3.51 | -13.66 | -15.76 |
| Low Estimate | -4.42 | -5.2 | -20.41 | -25.87 |
| High Estimate | -2.47 | -2.08 | -7.84 | -5.28 |
| Year Ago EPS | -4.68 | -5.46 | -19.5 | -13.66 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -4.94 | -5.33 | -4.58 | -3.18 |
| EPS Actual | -4.68 | -5.46 | -5.33 | -4.03 |
| Difference | 0.26 | -0.13 | -0.75 | -0.85 |
| Surprise % | 5.26% | -2.44% | -16.31% | -26.53% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -3.29 | -3.51 | -13.66 | -15.76 |
| 7 Days Ago | -3.61 | -3.84 | -15.25 | -18.93 |
| 30 Days Ago | -3.99 | -4.42 | -16.58 | -21.71 |
| 60 Days Ago | -3.64 | -3.96 | -14.3 | -19.28 |
| 90 Days Ago | -3.64 | -3.96 | -14.3 | -19.28 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 1 | 1 | 2 | 1 |
| Down Last 7 Days | 1 | 1 | -- | -- |
| Down Last 30 Days | 1 | 1 | 2 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| TPST | 29.63% | 35.71% | 29.93% | -15.32% |
| S&P 500 | 13.21% | 3.06% | 8.01% | 13.77% |
Upgrades & Downgrades
| Downgrade | Scotiabank: Sector Outperform to Sector Perform | 4/10/2025 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 4/10/2025 |
| Maintains | Scotiabank: Sector Outperform to Sector Outperform | 3/28/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/28/2025 |
| Maintains | Piper Sandler: Overweight to Overweight | 11/13/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/13/2024 |
Related Tickers
PALI Palisade Bio, Inc.
0.7546
-1.35%
DRUG Bright Minds Biosciences Inc.
32.49
+1.34%
XFOR X4 Pharmaceuticals, Inc.
3.3700
+2.43%
GNPX Genprex, Inc.
0.2853
-0.56%
ZVSA ZyVersa Therapeutics, Inc.
0.5272
-7.70%
ALXO ALX Oncology Holdings Inc.
0.4223
-8.24%
APVO Aptevo Therapeutics Inc.
0.3400
-5.56%
CCCC C4 Therapeutics, Inc.
1.4700
-4.55%
CNTB Connect Biopharma Holdings Limited
0.8098
+1.23%
SNSE Sensei Biotherapeutics, Inc.
0.3600
-4.41%